These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 21432614

  • 1. A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities.
    Rubio B, Hernández S, Verche E, Martín R, González-Pérez P.
    Atten Defic Hyperact Disord; 2011 Mar; 3(1):13-20. PubMed ID: 21432614
    [Abstract] [Full Text] [Related]

  • 2. [Neuropsychological assessment of the effectiveness of OROS-methylphenidate in attention deficit hyperactivity disorder].
    Rubio-Morell B, Martín-González R, Herreros-Rodríguez O, González-Pérez P, Hernández-Exposito S, Quintero-Fuentes I, Gracia-Marco R.
    Rev Neurol; 2011 Mar; 46(10):602-8. PubMed ID: 18465700
    [Abstract] [Full Text] [Related]

  • 3. Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder.
    Murray DW, Childress A, Giblin J, Williamson D, Armstrong R, Starr HL.
    Clin Pediatr (Phila); 2011 Apr; 50(4):308-20. PubMed ID: 21436147
    [Abstract] [Full Text] [Related]

  • 4. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.
    Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE.
    Can J Clin Pharmacol; 2006 Apr; 13(1):e50-62. PubMed ID: 16456216
    [Abstract] [Full Text] [Related]

  • 5. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 6. Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.
    Cho SC, Kim BN, Cummins TD, Kim JW, Bellgrove MA.
    J Psychopharmacol; 2012 Mar; 26(3):380-9. PubMed ID: 21628343
    [Abstract] [Full Text] [Related]

  • 7. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children].
    Pan XX, Ma HW, Wan B, Dai XM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):471-4. PubMed ID: 18706164
    [Abstract] [Full Text] [Related]

  • 8. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A, Krauel K, Hinrichs H, Fischer J, Malecki U, Schuetze H, Wolff S, Jansen O, Duezel E, Baving L.
    Brain Res; 2011 May 04; 1388():56-68. PubMed ID: 21385569
    [Abstract] [Full Text] [Related]

  • 9. Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD.
    Robison RJ, Reimherr FW, Gale PD, Marchant BK, Williams ED, Soni P, Halls C, Strong RE.
    Ann Clin Psychiatry; 2010 May 04; 22(2):94-102. PubMed ID: 20445836
    [Abstract] [Full Text] [Related]

  • 10. Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder.
    Zheng Y, Wang YF, Qin J, Wang LW, Zou LP, Jin XM, Xu T, Wang Y, Qi YL, Gong ME, Yin QY, Mai JN, Jing J, Luo XY, Ma HW, Li HB, Xie L, Li Y, Kuang GF, Yi MJ, Wang F, Zhu XH, Yao YB.
    Chin Med J (Engl); 2011 Oct 04; 124(20):3269-74. PubMed ID: 22088519
    [Abstract] [Full Text] [Related]

  • 11. Effects of MPH-OROS on the organizational, time management, and planning behaviors of children with ADHD.
    Abikoff H, Nissley-Tsiopinis J, Gallagher R, Zambenedetti M, Seyffert M, Boorady R, McCarthy J.
    J Am Acad Child Adolesc Psychiatry; 2009 Feb 04; 48(2):166-75. PubMed ID: 19127171
    [Abstract] [Full Text] [Related]

  • 12. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
    Durukan I, Türkbay T, Cöngöloğlu A.
    Turk Psikiyatri Derg; 2008 Feb 04; 19(4):358-64. PubMed ID: 19110977
    [Abstract] [Full Text] [Related]

  • 13. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
    Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M.
    J Am Acad Child Adolesc Psychiatry; 2003 Apr 04; 42(4):424-33. PubMed ID: 12649629
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.
    Tannock R, Ickowicz A, Schachar R.
    J Am Acad Child Adolesc Psychiatry; 1995 Jul 04; 34(7):886-96. PubMed ID: 7649959
    [Abstract] [Full Text] [Related]

  • 15. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T.
    Biol Psychiatry; 2006 May 01; 59(9):829-35. PubMed ID: 16373066
    [Abstract] [Full Text] [Related]

  • 16. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A, Richard C, Prinzo R, Binder C.
    Curr Med Res Opin; 2006 Dec 01; 22(12):2557-66. PubMed ID: 17166338
    [Abstract] [Full Text] [Related]

  • 17. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH.
    Sleep Med; 2007 Jan 01; 8(1):18-30. PubMed ID: 17157069
    [Abstract] [Full Text] [Related]

  • 18. Anxiety, methylphenidate response, and working memory in children with ADHD.
    Bedard AC, Tannock R.
    J Atten Disord; 2008 Mar 01; 11(5):546-57. PubMed ID: 18094325
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tolerability and effects of OROS® MPH (Concerta ®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial.
    Gerwe M, Stollhoff K, Mossakowski J, Kuehle HJ, Goertz U, Schaefer C, Bogdanow M, Heger S.
    Atten Defic Hyperact Disord; 2009 Dec 01; 1(2):175-86. PubMed ID: 21432582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.